PT Cipta Sarana Medika Tbk (IDX:DKHH)
Indonesia flag Indonesia · Delayed Price · Currency is IDR
65.00
-1.00 (-1.52%)
At close: May 26, 2026

IDX:DKHH Income Statement

Millions IDR. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
146,224144,873152,142134,18899,578105,656
Revenue Growth (YoY)
-2.94%-4.78%13.38%34.76%-5.75%-
Cost of Revenue
112,920111,927106,85691,66970,10569,119
Gross Profit
33,30432,94645,28642,51929,47336,537
Selling, General & Admin
29,94229,49633,97526,60619,13119,129
Other Operating Expenses
---2,871174.06415.02
Operating Expenses
29,94229,49633,97532,84522,32722,499
Operating Income
3,3623,45111,3119,6747,14614,038
Interest Expense
-9,865-10,242-11,556-7,223-3,512-4,618
Interest & Investment Income
12,29713,191----
Other Non Operating Income (Expenses)
549.33682.23411.33-267.521,072784.19
EBT Excluding Unusual Items
6,3437,081166.882,1844,70610,205
Gain (Loss) on Sale of Assets
-1,044-1,392-97.38-23.05-
Other Unusual Items
--3,2483,0321,379-
Pretax Income
5,2985,6893,3185,2156,10810,205
Income Tax Expense
132.99-332.96480.371,6761,2202,304
Earnings From Continuing Operations
5,1656,0222,8373,5404,8887,901
Minority Interest in Earnings
--0.25-0.13---
Net Income
5,1656,0222,8373,5404,8887,901
Net Income to Common
5,1656,0222,8373,5404,8887,901
Net Income Growth
224.05%112.24%-19.85%-27.59%-38.13%-
Shares Outstanding (Basic)
2,3642,364800555555309
Shares Outstanding (Diluted)
2,3642,364800555555309
Shares Change (YoY)
98.46%195.43%44.27%-79.52%-
EPS (Basic)
2.182.553.556.388.8125.57
EPS (Diluted)
2.182.553.556.388.8125.57
EPS Growth
63.28%-28.16%-44.44%-27.59%-65.54%-
Free Cash Flow
734.11-21,823-21,450-16,411-9,24722,887
Free Cash Flow Per Share
0.31-9.23-26.80-29.59-16.6774.07
Gross Margin
22.78%22.74%29.77%31.69%29.60%34.58%
Operating Margin
2.30%2.38%7.43%7.21%7.18%13.29%
Profit Margin
3.53%4.16%1.86%2.64%4.91%7.48%
Free Cash Flow Margin
0.50%-15.06%-14.10%-12.23%-9.29%21.66%
EBITDA
15,37715,44820,39117,42915,48319,863
EBITDA Margin
10.52%10.66%13.40%12.99%15.55%18.80%
D&A For EBITDA
12,01611,9979,0807,7558,3375,825
EBIT
3,3623,45111,3119,6747,14614,038
EBIT Margin
2.30%2.38%7.43%7.21%7.18%13.29%
Effective Tax Rate
2.51%-14.48%32.13%19.97%22.58%
Source: S&P Global Market Intelligence. Standard template. Financial Sources.